UK Organ Preservation Market (2025-2030)
The UK Organ Preservation Market was valued at $6.46 Million in 2025 and projected to reach to $7.64 Million by 2030, representing a compound annual growth rate of CAGR 3.4%. The UK organ preservation market is positioned for steady expansion through 2030, driven by NHS investment in transplant infrastructure and growing clinical adoption of advanced preservation technologies.
UK Organ Preservation Market Trends and Insights
- The UK market reflects steady demand driven by advances in preservation technologies and increasing transplant procedures across the National Health Service.
- The UK's established healthcare infrastructure and regulatory framework support adoption of innovative organ preservation solutions that extend viability windows and improve transplant outcomes. Growth in the UK organ preservation market is underpinned by rising organ donation rates and investment in transplant centres.
- The UK continues to strengthen its position as a leader in transplantation, with organ preservation technologies playing a critical role in reducing organ wastage and improving graft survival.
- Between 2025 and 2030, the UK market will benefit from enhanced clinical protocols and greater awareness of preservation benefits among healthcare providers..
Key Market Statistics
- CAGR (2025-2030) CAGR 3.4%
- Market Size, 2025 ~USD 6.46 Million
- Forecast, 2030 ~USD 7.64 Million
- Country UK
UK Organ Preservation Market Overview
Market Valuation :
The UK organ preservation market is valued at £6.46 million in 2025, with projections reaching £7.64 million by 2030, representing steady growth in the healthcare sector.
NHS-Driven Demand :
Growth is primarily driven by increasing transplant procedures across the National Health Service, with organ preservation technologies becoming critical to improving transplant success rates and patient outcomes.
Regulatory Framework :
The UK's established healthcare infrastructure and stringent regulatory environment support adoption of advanced preservation technologies, ensuring compliance with MHRA and NHS standards.
Technology Advancement :
Continuous innovations in preservation solutions and cold chain management are enhancing organ viability, reducing transplant rejection rates, and expanding the donor pool across UK hospitals.
UK Organ Preservation Market Dynamics
- Increasing organ donation awareness campaigns and improved donor management protocols are expanding the available donor pool, necessitating more sophisticated preservation solutions.
- The market will benefit from regulatory support and healthcare funding initiatives aimed at reducing transplant waiting times.
- However, growth remains moderate compared to global markets, reflecting the UK's mature healthcare system and established transplant protocols.
- Strategic partnerships between NHS trusts and preservation technology providers will be key to market development..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- The UK organ preservation market is valued at £6.46 million in 2025 and will reach £7.64 million by 2030 at a 3.4% CAGR.
- The UK's NHS-driven transplant infrastructure creates steady demand for organ preservation technologies and solutions.
- Regulatory support and clinical innovation in the UK are accelerating adoption of advanced preservation methods.
- The UK market growth is constrained by moderate expansion compared to global rates, reflecting mature healthcare adoption patterns.
Organ Preservation Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PERFADEX (Solution) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.8% from 2025 to 2030 |
| Largest Segment | ORGAN TRANSPLANT CENTERS (End User) |
| Market Size Base Year (Billions) | ~USD 0.22 (2025) |
| Revenue Forecast (Billions) | ~USD 0.3 (2030) |
| Segments Covered | Solution, Technique, Organ Type, End User |
UK Organ Preservation Market Report Segmentation
4 segment dimensions are covered across the global market.
By Solution
- Custodiol Htk
- Other Solutions
- Perfadex
- University Of Wisconsin Solution
By Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Static Cold Storage
By Organ Type
- Heart
- Kidneys
- Liver
- Lungs
- Other Organs
By End User
- Hospitals
- Organ Transplant Centers
- Specialty Clinics
Target Audience
- Medical Device Manufacturers : Manufacturers of organ preservation systems need UK-specific market data to develop localized product strategies, navigate NHS procurement processes, and identify partnership opportunities with transplant centers.
- NHS Trusts & Transplant Centers : Hospital procurement teams and transplant coordinators require market insights to evaluate preservation technology options, benchmark against peer institutions, and justify capital investments.
- Healthcare Investors & PE Firms : Investment professionals evaluating UK healthcare opportunities need detailed market sizing, growth projections, and competitive analysis to assess acquisition targets and portfolio companies.
- Pharmaceutical & Biotech Companies : Organizations developing preservation solutions and perfusion technologies need UK market intelligence to guide R&D investments, clinical trial planning, and commercialization strategies.
- Healthcare Consultants & Advisors : Strategy consultants supporting NHS modernization initiatives and healthcare providers need authoritative UK market data to inform recommendations and business case development.
Key Companies in the UK Organ Preservation Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Static Cold Storage–linked care (all solutions),Hypothermic machine perfusion–linked care,Normothermic perfusion–linked care, |
| XVIVO PERFUSION AB | Sweden | Public Company | Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions, |
| TRANSMEDICS, INC. | United States | Public Company | OCS Heart,OCS Lung,OCS Liver, |
| BIOLIFE SOLUTIONS, INC. | United States | Public Company | HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport), |
| SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms), |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.
XVIVO PERFUSION AB
XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.
TRANSMEDICS, INC.
TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.
BIOLIFE SOLUTIONS, INC.
BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.
Reasons to Buy this Report
- NHS Market Intelligence : Gain detailed insights into NHS procurement patterns, transplant volumes, and funding allocations to identify opportunities within the UK's largest healthcare buyer.
- Competitive Landscape Analysis : Understand UK-specific competitive dynamics, key players, market share distribution, and differentiation strategies among organ preservation solution providers.
- Regulatory & Compliance Guidance : Access comprehensive information on MHRA regulations, NHS standards, and compliance requirements specific to organ preservation devices and solutions in the UK market.
- Growth Opportunity Identification : Identify emerging segments, underserved regions within the UK, and expansion opportunities driven by transplant center modernization and increased donation rates.
- Strategic Decision Support : Make informed investment, partnership, and market entry decisions with validated UK market data, forecasts, and trend analysis through 2030.
Frequently asked questions
What is the current size of the UK organ preservation market?
The UK organ preservation market is valued at £6.46 million in 2025 and is expected to grow to £7.64 million by 2030.
What is the growth rate of the UK organ preservation market?
The UK organ preservation market is growing at a compound annual growth rate of 3.4% from 2025 to 2030.
What factors are driving growth in the UK organ preservation market?
Growth in the UK is driven by increased organ donation rates, NHS investment in transplant centres, advances in preservation technologies, and improved clinical protocols.
How does the UK market compare to global organ preservation trends?
The UK market grows at 3.4% CAGR, which is slower than the global rate of 6.8%, reflecting a more mature and established transplant infrastructure.
Which organ preservation technologies are most adopted in the UK?
The UK primarily adopts static cold storage and machine perfusion technologies, with increasing interest in normothermic perfusion systems for extended preservation.
RESEARCH METHODOLOGY
The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.
This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.
Primary Research
Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the organ preservation market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach
Data Triangulation
The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.
Market Definition
Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.
Stakeholders
- Association of Organ Procurement Organizations (AOPO)
- American Transplant Congress (ATC)
- United Network for Organ Sharing (UNOS)
- Network & Alliance of Transplant Coordinators (NATCO)
- Consortium for Organ Preservation in Europe (COPE)
- European Society for Organ Transplantation (ESOT)
- Asian Society of Transplantation (AST)
- National Health Service (UK NHS)
- International Registry on Organ Donation and Transplantation (IRODaT)
- Global Observatory on Donation and Transplants (GODT)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
- Organisation for Economic Co-operation and Development (OECD)
- Centers for Disease Control and Prevention (CDC)
- Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
- White Papers, Journals/Magazines, and News Articles
Report Objectives
- To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
- To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering
Get the Full Organ Preservation Market Report
Full forecast, segment splits, and company analysis for all Organ Preservation Market.
- US Organ Preservation Market
- Canada Organ Preservation Market
- Germany Organ Preservation Market
- France Organ Preservation Market
- Spain Organ Preservation Market
- Italy Organ Preservation Market
- China Organ Preservation Market
- Japan Organ Preservation Market
- India Organ Preservation Market
- Australia Organ Preservation Market
- South Korea Organ Preservation Market
- Brazil Organ Preservation Market
- Mexico Organ Preservation Market
- GCC Countries Organ Preservation Market
- Roe Organ Preservation Market
- Rest Of Asia Pacific Organ Preservation Market
- Rest Of Europe Organ Preservation Market
- Rest Of Latin America Organ Preservation Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report